P3 Health Partners Inc. (NASDAQ:PIII) finished Friday with a subtraction of -$0.01 to close at $1.39, a downside of -1.07 percent. An average of 472,780 shares of common stock have been traded in the last five days. There was a fall of -$0.2700 in the past week, and it reached a new high 7 times over the past 12 months. The last 20 days have seen an average of 289,230 shares traded, while the 50-day average volume stands at 442,878.
PIII stock has decreased by -33.01% in the last month. The company shares reached their 1-month lowest point of $1.3050 on 08/25/23. With the stock rallying to its 52-week high on 06/06/23, shares of the company touched a low of $0.70 and a high of $7.05 in 52 weeks. It has reached a new high 9 times so far this year and lost -24.46% or -$0.4500 in price. In spite of this, the price is down -80.28% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
P3 Health Partners Inc. (PIII) stock’s beta is 1.42. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.38.
Financial Health
The quick ratio of P3 Health Partners Inc. for the three months ended June 29 was 0.70, and the current ratio was 0.70, indicating that the company is not able to meet its debt obligations. P3 Health Partners Inc.’s EBITDA margin for the year ending June 29 is -15.12%, while its operating margin for the same period stands at -58.60%. Its gross profit as reported stood at -$7.75 million compared to revenue of $1.05 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, P3 Health Partners Inc.’s return on assets was -12.30%.
Earnings Surprise
For the three-month period that ended June 29, P3 Health Partners Inc. had $108.19 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$9.82 million in the quarter, while revenues of -$9.2 million were shrunk -1471.79%. The analyst consensus anticipated P3 Health Partners Inc.’s latest quarter earnings to come in at -$0.13 per share, but it turned out to be -$0.09, a 30.80% surprise. For the quarter, EBITDA amounted to $0.81 million. Shareholders own equity worth $312.68 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at P3 Health Partners Inc. (PIII) price momentum. RSI 9-day as of the close on 25 August was 14.44%, suggesting the stock is oversold, with historical volatility in this time frame at 52.47%.
As of today, PIII’s price is $1.5050 -16.27% or -$0.2700 from its 5-day moving average. PIII is currently trading -35.80% lower than its 20-day SMA and +34.30% higher than its 100-day SMA. However, the stock’s current price level is -66.10% below the SMA50 and -70.92% below the SMA200.
The stochastic %K and %D were 3.35% and 2.71%, respectively, and the average true range (ATR) was 0.1769. With the 14-day stochastic at 5.76% and the average true range at 0.1963, the RSI (14) stands at 21.24%. The stock has reached -0.1306 on the 9-day MACD Oscillator while the 14-day reading was at -0.3140.
Analyst Ratings
TD Cowen launched coverage on P3 Health Partners Inc. (NASDAQ: PIII) in its analyst report released on June 30, 2023. The firm assigned the stock a Market perform rating. The consensus rating for P3 Health Partners Inc. (PIII) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell PIII, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.
What is PIII’s price target for the next 12 months?
Analysts predict a range of price targets between $3.50 and $9.00, with a median target of $4.00. Taking a look at these predictions, the average price target given by analysts for P3 Health Partners Inc. (PIII) stock is $5.50.
